A Randomized Controlled Trial to Assess the Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients for Optimum Treatment Outcomes in a Primary Medical Center in Jordan
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 103
- 试验地点
- 1
- 主要终点
- HbA1c
研究概览
简要总结
This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.
详细描述
About 103 patients with type 2 diabetes were randomized to control or intervention group, the control group received a standard care, while the intervention group received the collaborative care between the clinical pharmacist and physicians. Fasting blood glucose, HbA1c, Lipid profile, and blood pressure measured for both groups at baseline and after three months of follow-up. Treatment related problems (TRPs), quality of life, adherence, and patients knowledge about their medications were assessed. Cost avoidance and clinical significance of implemented clinical pharmacist interventions were assessed too.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •type 2 diabetic patients who aged 18 years or more with a HbA1c reading 6.5 % or more at the time of diagnosis
排除标准
- •pregnant patients
- •breastfeeding patients
- •patients with urgent or emergent cases
- •patients with cognitive impairment
- •if the patient is unable to provide informed written consent
结局指标
主要结局
HbA1c
时间窗: 3 months
次要结局
- Lipid profile(3 months)
- Fasting blood glucose(each month for 3 months)
- Patients knowledge about their medications(3 months)
- Cost avoidance of implemented clinical pharmacist interventions(3 months)
- Patients adherence to medications(3 months)
- Quality of life(3 months)
- Blood pressure(3 months)
研究者
Jyana Alelaimat
Master student at the University of Jordan
University of Jordan